112 related articles for article (PubMed ID: 25740629)
1. The status of donor cancer tissues affects the fate of patient-derived colorectal cancer xenografts in NOG mice.
Fujii E; Kato A; Chen YJ; Matsubara K; Ohnishi Y; Suzuki M
Exp Anim; 2015; 64(2):181-90. PubMed ID: 25740629
[TBL] [Abstract][Full Text] [Related]
2. Histopathological characteristics of human non-tumor thyroid tissues in a long-term model of adenomatous goiter xenografts in the NOD/Shi-scid, IL-2Rγ(null) mouse.
Fujii E; Kato A; Chen YJ; Matsubara K; Ohnishi Y; Suzuki M
Exp Toxicol Pathol; 2014 Jul; 66(4):203-9. PubMed ID: 24589354
[TBL] [Abstract][Full Text] [Related]
3. Characterization of EBV-related lymphoproliferative lesions arising in donor lymphocytes of transplanted human tumor tissues in the NOG mouse.
Fujii E; Kato A; Chen YJ; Matsubara K; Ohnishi Y; Suzuki M
Exp Anim; 2014; 63(3):289-96. PubMed ID: 25077758
[TBL] [Abstract][Full Text] [Related]
4. Spontaneous Post-Transplant Disorders in NOD.Cg- Prkdcscid Il2rgtm1Sug/JicTac (NOG) Mice Engrafted with Patient-Derived Metastatic Melanomas.
Radaelli E; Hermans E; Omodho L; Francis A; Vander Borght S; Marine JC; van den Oord J; Amant F
PLoS One; 2015; 10(5):e0124974. PubMed ID: 25996609
[TBL] [Abstract][Full Text] [Related]
5. NOG-hIL-4-Tg, a new humanized mouse model for producing tumor antigen-specific IgG antibody by peptide vaccination.
Kametani Y; Katano I; Miyamoto A; Kikuchi Y; Ito R; Muguruma Y; Tsuda B; Habu S; Tokuda Y; Ando K; Ito M
PLoS One; 2017; 12(6):e0179239. PubMed ID: 28617827
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous xenogeneic GvHD in Wilms' tumor Patient-Derived xenograft models and potential solutions.
Monzavi SM; Muhammadnejad A; Behfar M; Khorsand AA; Muhammadnejad S; Kajbafzadeh AM
Animal Model Exp Med; 2022 Dec; 5(4):389-396. PubMed ID: 35726155
[TBL] [Abstract][Full Text] [Related]
7. Optimized Xenograft Protocol for Chronic Lymphocytic Leukemia Results in High Engraftment Efficiency for All CLL Subgroups.
Decker S; Zwick A; Khaja Saleem S; Kissel S; Rettig A; Aumann K; Dierks C
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31842407
[TBL] [Abstract][Full Text] [Related]
8. Induction of human humoral immune responses in a novel HLA-DR-expressing transgenic NOD/Shi-scid/γcnull mouse.
Suzuki M; Takahashi T; Katano I; Ito R; Ito M; Harigae H; Ishii N; Sugamura K
Int Immunol; 2012 Apr; 24(4):243-52. PubMed ID: 22402880
[TBL] [Abstract][Full Text] [Related]
9. Reconstitution of severe combined immunodeficient mice with intrathyroidal lymphocytes of thyroid xenografts from patients with Hashimoto's thyroiditis.
Akasu F; Morita T; Resetkova E; Miller N; Akasu R; Jamieson C; Volpé R
J Clin Endocrinol Metab; 1993 Jan; 76(1):223-30. PubMed ID: 7678424
[TBL] [Abstract][Full Text] [Related]
10. Establishment of primary patient-derived xenografts of palliative TURP specimens to study castrate-resistant prostate cancer.
Lawrence MG; Pook DW; Wang H; Porter LH; Frydenberg M; Kourambas J; Appu S; Poole C; Beardsley EK; Ryan A; Norden S; Papargiris MM; Risbridger GP; Taylor RA
Prostate; 2015 Sep; 75(13):1475-83. PubMed ID: 26177841
[TBL] [Abstract][Full Text] [Related]
11. Umbilical cord blood xenografts in immunodeficient mice reveal that T cells enhance hematopoietic engraftment beyond overcoming immune barriers by stimulating stem cell differentiation.
Hexner EO; Danet-Desnoyers GA; Zhang Y; Frank DM; Riley JL; Levine BL; Porter DL; June CH; Emerson SG
Biol Blood Marrow Transplant; 2007 Oct; 13(10):1135-44. PubMed ID: 17889349
[TBL] [Abstract][Full Text] [Related]
12. Responses to donor lymphocyte infusion for acute lymphoblastic leukemia may be determined by both qualitative and quantitative limitations of antileukemic T-cell responses as observed in an animal model for human leukemia.
Nijmeijer BA; van Schie ML; Verzaal P; Willemze R; Falkenburg JH
Exp Hematol; 2005 Oct; 33(10):1172-81. PubMed ID: 16219539
[TBL] [Abstract][Full Text] [Related]
13. Patient-derived xenografts of gastrointestinal cancers are susceptible to rapid and delayed B-lymphoproliferation.
Dieter SM; Giessler KM; Kriegsmann M; Dubash TD; Möhrmann L; Schulz ER; Siegl C; Weber S; Strakerjahn H; Oberlack A; Heger U; Gao J; Hartinger EM; Oppel F; Hoffmann CM; Ha N; Brors B; Lasitschka F; Ulrich A; Strobel O; Schmidt M; von Kalle C; Schneider M; Weichert W; Ehrenberg KR; Glimm H; Ball CR
Int J Cancer; 2017 Mar; 140(6):1356-1363. PubMed ID: 27935045
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the NOD/scid-[Tg]DR1 mouse expressing HLA-DRB1*01 transgene: a model of SCID-hu mouse for vaccine development.
Camacho RE; Wnek R; Fischer P; Shah K; Zaller DM; Woods A; La Monica N; Aurisicchio L; Fitzgerald-Bocarsly P; Koo GC
Exp Hematol; 2007 Aug; 35(8):1219-30. PubMed ID: 17662890
[TBL] [Abstract][Full Text] [Related]
15. Multilineage hematopoietic engraftment after allogeneic peripheral blood stem cell transplantation without conditioning in SCID patients.
Bielorai B; Trakhtenbrot L; Amariglio N; Rothman R; Tabori U; Dallal I; Golan H; Neumann Y; Reichart M; Kaplinsky C; Rechavi G; Toren A
Bone Marrow Transplant; 2004 Aug; 34(4):317-20. PubMed ID: 15220954
[TBL] [Abstract][Full Text] [Related]
16. Engraftment of human lymphocytes and thyroid tissue into scid and rag2-deficient mice: absent progression of lymphocytic infiltration.
Martin A; Valentine M; Unger P; Yeung SW; Shultz LD; Davies TF
J Clin Endocrinol Metab; 1994 Sep; 79(3):716-23. PubMed ID: 8077352
[TBL] [Abstract][Full Text] [Related]
17. Establishment of a humanized model of liver using NOD/Shi-scid IL2Rgnull mice.
Suemizu H; Hasegawa M; Kawai K; Taniguchi K; Monnai M; Wakui M; Suematsu M; Ito M; Peltz G; Nakamura M
Biochem Biophys Res Commun; 2008 Dec; 377(1):248-52. PubMed ID: 18840406
[TBL] [Abstract][Full Text] [Related]
18. Efficient xenoengraftment in severe immunodeficient NOD/Shi-scid IL2rγnull mice is attributed to a lack of CD11c+B220+CD122+ cells.
Ito R; Katano I; Ida-Tanaka M; Kamisako T; Kawai K; Suemizu H; Aiso S; Ito M
J Immunol; 2012 Nov; 189(9):4313-20. PubMed ID: 23018460
[TBL] [Abstract][Full Text] [Related]
19. Multiple integrations of human T-lymphotropic virus type 1 proviruses in the engrafted cells from the asymptomatic carriers in NOD/SCID/gammacnull mice.
Yamamoto I; Takajo I; Umeki K; Morishita K; Hatakeyama K; Kataoka H; Nomura H; Okayama A
Intervirology; 2010; 53(4):229-39. PubMed ID: 20357492
[TBL] [Abstract][Full Text] [Related]
20. The effect of adding a surfeit of autologous CD8+ T cells to SCID mice after secondary rexenografts of Graves' thyroid tissue.
Mukuta T; Nishikawa M; Arreaza G; Resetkova E; Yoshikawa N; Fornasier V; Young E; Volpé R
Thyroid; 1996 Oct; 6(5):429-36. PubMed ID: 8936667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
